sodium (R,R,2R,2'R,4S,4'S,5R,5'R,6R,6'R)-2,2'-(((2,2'-(terephthaloylbis(azanediyl))bis(ethane-2,1-diylsulfinyl))bis(propane-3,1-diyl))bis(oxy))bis(6-((1R,2R)-3-([1,1'-biphenyl]-4-ylcarboxamido)-1,2-dihydroxypropyl)-5-acetamido-4-hydroxytetrahydro-2H-pyran-2-carboxylate)

ID: ALA5172051

Chembl Id: CHEMBL5172051

PubChem CID: 168270805

Max Phase: Preclinical

Molecular Formula: C66H78N6Na2O22S2

Molecular Weight: 1373.52

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNC(=O)c2ccc(-c3ccccc3)cc2)O[C@@](OCCC[S+]([O-])CCNC(=O)c2ccc(C(=O)NCC[S+]([O-])CCCO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(-c5ccccc5)cc4)O3)cc2)(C(=O)[O-])C[C@@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C66H80N6O22S2.2Na/c1-39(73)71-53-49(75)35-65(63(85)86,93-57(53)55(79)51(77)37-69-61(83)47-19-15-43(16-20-47)41-11-5-3-6-12-41)91-29-9-31-95(89)33-27-67-59(81)45-23-25-46(26-24-45)60(82)68-28-34-96(90)32-10-30-92-66(64(87)88)36-50(76)54(72-40(2)74)58(94-66)56(80)52(78)38-70-62(84)48-21-17-44(18-22-48)42-13-7-4-8-14-42;;/h3-8,11-26,49-58,75-80H,9-10,27-38H2,1-2H3,(H,67,81)(H,68,82)(H,69,83)(H,70,84)(H,71,73)(H,72,74)(H,85,86)(H,87,88);;/q;2*+1/p-2/t49-,50-,51+,52+,53+,54+,55+,56+,57+,58+,65+,66+,95?,96?;;/m0../s1

Standard InChI Key:  VPGVKHBLQSZHFU-FKTQTVOXSA-L

Associated Targets(Human)

CD22 Tclin CD22 (125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1373.52Molecular Weight (Monoisotopic): 1372.4767AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L..  (2022)  Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics.,  65  (15.0): [PMID:35881556] [10.1021/acs.jmedchem.2c00765]

Source